Arnica tincture for treating cutaneous leishmaniasis
Part of Infections, Skin clinical trials.
This trial tests whether arnica tincture (a plant extract) can treat cutaneous leishmaniasis, an infection causing skin ulcers. It compares arnica to a standard injected treatment and looks at how well each works and how safe they are.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are at least 12 years old and have been diagnosed with cutaneous leishmaniasis (a skin infection confirmed by lab tests)
- You have up to 9 skin sores (ulcers, nodules, or plaques) that together are no larger than about 1.9 inches (2.5 cm) across
- You have not had treatment for leishmaniasis in the last 8 weeks (56 days)
- You are not pregnant, breastfeeding, or planning to become pregnant during the study (if female of childbearing age, you must use birth control)
- You have no serious heart, kidney, liver, nerve, or immune system problems, and no allergies to arnica or pentavalent antimonials
- You can attend follow-up visits for up to 3 months and follow the study rules
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests whether adding a special medicine (an antimicrobial adjuvant) to the standard treatment for complicated skin sores caused by leishmaniasis can improve healing. It is for people in Ethiopia with sores that are large, many, or in sensitive areas.
This study tests how your immune system responds to parts of a potential vaccine for leishmaniasis. Doctors will take small blood or skin samples to see if your body's cells react to these vaccine pieces, which could help design a better vaccine in the future.
This study watches how leishmaniasis affects children over time. It helps doctors learn more about the disease in kids so they can improve care.
This study compares different drugs to find the best one for treating cutaneous leishmaniasis, a skin infection that causes sores. You might get one of several treatments, and the goal is to see which works best and is safest for patients like you.
This trial tests whether adding a special laser treatment (fractional CO₂ laser) to the standard injected medicine (Glucantime) helps heal skin sores from a parasite infection better than the medicine alone. It may offer a more effective way to clear the sores and improve healing.
This study tests whether applying a heat pack to skin sores caused by cutaneous leishmaniasis can help treat them. It's for people who cannot take the standard medication or prefer a non-drug option.
Hear when a new Leishmaniasis, Cutaneous trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.